We are live on ! Find out more
ASMB icon

Assembly Biosciences
ASMB

28 hedge funds and large institutions have $5.77M invested in Assembly Biosciences in 2014 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 4

18% less funds holding

Funds holding: 34 → 28 (-6)

30% less call options, than puts

Call options by funds: $21K | Put options by funds: $30K

46% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 13

84% less capital invested

Capital invested by funds: $37.2M → $5.77M (-$31.5M)

Holders
28
Holders Change
-6
Holders Change %
-17.65%
% of All Funds
0.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
9
Reduced
4
Closed
13
Calls
$21K
Puts
$30K
Net Calls
-$9K
Net Calls Change
-$109K

Top Buyers

Rank Fund Capital Flow
1
BIT
BlackRock Institutional Trust
California
+$1.2M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$312K
3
Goldman Sachs
Goldman Sachs
New York
+$275K
4
Citadel Advisors
Citadel Advisors
Florida
+$234K
5
Group One Trading
Group One Trading
Illinois
+$126K

Top Sellers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
-$7.07M
2
EM
Elliott Management
New York
-$6.81M
3
TAM
THB Asset Management
Connecticut
-$3.89M
4
BBA
Baker Bros. Advisors
New York
-$2.07M
5
TC
TFS Capital
Pennsylvania
-$828K
Name Holding Trade Value Shares
Change 		Change in
Stake
Manulife (Manufacturers Life Insurance)
26
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1 – – –
BC
27
Broadfin Capital
New York
– -$7.07M -30,831 Closed
EM
28
Elliott Management
New York
– -$6.81M -29,786 Closed
TAM
29
THB Asset Management
Connecticut
– -$3.89M -16,968 Closed
TC
30
TFS Capital
Pennsylvania
– -$828K -3,611 Closed
JGC
31
J. Goldman & Co
New York
– -$668K -2,917 Closed
NI
32
Numeric Investors
Massachusetts
– -$310K -1,352 Closed
DS
33
DRW Securities
Illinois
– -$306K -1,333 Closed
WC
34
Woodstock Corp
Massachusetts
– -$64K -281 Closed
PPA
35
Parametric Portfolio Associates
Washington
– -$55K -240 Closed
HighTower Advisors
36
HighTower Advisors
Illinois
– -$54K -234 Closed
FNYS
37
First New York Securities
New York
– -$34K -150 Closed
Bank of America
38
Bank of America
North Carolina
– -$2K -8 Closed
HCC
39
Hirtle Callaghan & Co
Pennsylvania
– -$1K -3 Closed
Barclays
40
Barclays
United Kingdom
– +$312 +2 New
1
2

ASMB Hedge Fund Activity: Q1 2014 in Review

28 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q1 2014, worth a combined $5.77M — down 84% from $37.2M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of ASMB and 7 opened new positions — a net loss of 6 holders — while 4 trimmed existing stakes and 9 added.

The largest buyer was BlackRock Institutional Trust, adding an estimated $1.2M. The largest seller was Broadfin Capital, exiting entirely with an estimated $7.07M sold.

  • 28 institutional investors held Assembly Biosciences (ASMB) as of Q1 2014, down from 34 in Q4 2013.
  • Funds reported $5.77M of Assembly Biosciences stock for Q1 2014, down 84% quarter-over-quarter.
  • 7 funds opened new Assembly Biosciences positions in Q1 2014 and 13 closed out, a net change of -6 holders.
  • The largest Assembly Biosciences buyer in Q1 2014 was BlackRock Institutional Trust, an estimated $1.2M added.
  • The largest Assembly Biosciences seller in Q1 2014 was Broadfin Capital, an estimated $7.07M sold.

Based on aggregated 13F filings for Q1 2014.